Uptake and predictors of direct-acting antiviral treatment for hepatitis C among people receiving opioid agonist therapy in Sweden and Norway: a drug utilization study from 2014 to 2017

Treatment with direct-acting antiviral agents (DAAs) offers an opportunity to eliminate hepatitis C virus (HCV) endemic among people who inject drugs (PWID) and people enrolled in opioid agonist therapy (OAT) ...

Source: Substance Abuse Treatment, Prevention, and Policy - June 30, 2020 Category: Addiction Authors: Christer F. Aas, J ørn Henrik Vold, Svetlana Skurtveit, Ingvild Odsbu, Fatemeh Chalabianloo, Aaron G. Lim, Kjell Arne Johansson and Lars Thore Fadnes Tags: Research Source Type: research